ArticleCancer biology & therapy2021

MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway.

Qian Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.